Thank you, David. Good morning, everyone. Turning to slide seven, we delivered sales in the third quarter of $254.1 million, up 10.3% from the prior year period, or 8.5% on a constant currency basis. This was at the high end of the guidance we provided last quarter, supported by strong execution from the team and continued resilience in demand. The Montrotec acquisition contributed $15.5 million to net sales, accounting for 6.7% of the net sales increase. Montrotec had a very strong quarter, reflecting the timing of several large project deliveries, namely to Airbus and a large German automotive company in the EV space. We realized pricing gains of $6.5 million, or 2.8%, which was in line with what we were anticipating as we lapped last year's November price increase. Volume decreased by $2.4 million, or 1%. This was largely in our precision conveyance platform, which was impacted by lower order rates earlier in the fiscal year. As David discussed, the funnel is healthy for this platform, and we saw strong order growth of 23.5% in Q3. Foreign currency translation was a benefit this quarter of $4.1 million, or 1.8%. We saw robust growth outside of the U.S., with sales increasing by 30%. This was the result of a combination of both Montrotec revenue and high single-digit organic growth. In the U.S., sales decreased 2% on lower volumes, primarily in our precision conveyance platform as just referenced. On slide eight, we recorded gross margin of 36.9% in the third quarter. On an adjusted basis, gross margin was 37.2%, up 160 basis points year-over-year. As expected, we saw adjusted gross margin decline sequentially by 150 basis points, which includes normal seasonality. While gross margins were the highest we ever had in a third quarter, we came in a little behind our expectations. This was primarily driven by a COVID outbreak in December in our Kunstleslau, Germany, factory that impacted labor productivity. In addition, at Montrotec, we had higher purchase components for a particular project that carried a lower margin, which we have addressed and should not repeat. Q4 margins will rebound, and we remain on our path to achieve 40% gross margins in fiscal '27. Gross profit increased $11.8 million, or 14% versus the prior year. This was driven by several factors, which you can see in the table. The largest item driving gross profit expansion were contributions from the Montrotec acquisition, which contributed $6.7 million to gross profit, and pricing net of manufacturing cost changes, including material inflation, which added $4.6 million. Montrotec was accretive to gross margins by 40 basis points this quarter, with an overall gross margin of 43%. Moving to slide 9, our SG&A expense was $59.5 million in the quarter, or 23.4% of sales. This was improved 70 basis points from a year ago. The year-over-year increase was largely from the addition of Montrotec to the portfolio and the impact of FX, which added 800,000 to the total. We continue to invest in R&D, which added $1.4 million to the total, but this was more than offset by an acquisition earn out in the prior year that did not repeat and lower selling costs as we realigned the business a year ago. Turning to slide 10, we generated operating income of $26.9 million in the quarter, or 10.6% of sales. This represents an increase of $6.7 million, or 33% over last year's third quarter. Adjusted operating income was $29.7 million, or 11.7% of sales. On an adjusted basis, operating income grew $6.3 million, or 27%. This reflects the strong operating leverage we have in the business and demonstrates our long runway for margin expansion over time. Excluding the Montrotec acquisition, which was additive to our results, our business drove 47% adjusted operating leverage. As you can see on slide 11, we recorded GAAP earnings per diluted share for the quarter of $0.34, down $0.8 versus the prior year. This was due to a $4.6 million non-cash pension settlement expense, which impacted EPS by $0.12 per share. We are in the process of terminating one of our U.S. pension plans. We paid lump sum payments to a certain class of current and former employees who elected the lump sum settlement. The remaining liability will be sold to an insurance company later this calendar year. When we complete that transaction, we expect another non-cash charge of approximately $28 million to $29 million that we will record. At that point, the pension plan will be off our books. We had a similar termination back in fiscal year '21. We have adjusted this out for purposes of calculating adjusted EPS. Our tax rate on a GAAP basis this quarter was 29% as we repatriated overseas cash to accelerate debt repayment, which resulted in dividend withholding taxes. Year-to-date, our tax rate was 26%, and for the year, we still expect our tax rate to be approximately 25%. Adjusted earnings per diluted share of $0.74 was up $0.2 from the prior year. This higher adjusted operating income more than offset the negative impact of higher interest expense and the increased tax rate year-over-year, which together impacted EPS by about $0.10 per share in the quarter. On slide 12, our adjusted EBITDA margin this quarter of 16.3% improved by 160 basis points from a year ago. On a trailing 12-month basis, our adjusted EBITDA margin was also 16.3%, a 50 basis point improvement from where we finished fiscal year '23. Our return on invested capital continues to improve and was up 30 basis points from fiscal year '23 to 7%. We expect to realize a low double-digit ROIC by fiscal year '27. Moving to slide 13, quarterly free cash flow was $23.1 million in the period. This includes cash provided by operating activities of $29.1 million and CapEx of $6 million. Year-to-date, our free cash flow is $12.3 million, which is an increase of 66% from a year ago despite the higher CapEx, largely tied to our new Monterey, Mexico facility. Q4 historically is a strong cash from operations quarter for us, and we would expect that trend to continue. Turning to slide 14, our capital structure continues to improve as our net debt leverage ratio was 2.6 times on a financial covenant basis. As we have previously discussed, we have a covenant-like credit agreement. We continue to accelerate our debt reduction plans as we pay down another $15 million of debt this quarter. We are planning to pay down an additional $15 million in Q4, which will bring the total to $55 million of debt this fiscal year, up from the $40 million discussed at the beginning of the fiscal year. We expect to report a net leverage ratio of approximately 2.3 times as we exit fiscal year '24. Turning to guidance on slide 15, on the back of solid growth and orders in Q3, we expect to continue to grow net sales between 2% and 6% to between $260 million to $270 million in Q4. We also expect roughly $60 million of our SG&A expense, $10 million of interest expense, a tax rate of 25% for the full year, diluted shares outstanding of $29.1 million. We expect to continue to be highly cash flow generative with free cash flow conversion of approximately 90% for the full fiscal year. This is inclusive of Q4 CapEx of approximately $14 million to $19 million, which is elevated due to the opening of our Monterey facility. We expect to use our cash flow to continue to de-lever our business. As a result, we expect our net leverage ratio to improve to approximately 2.3 times by the end of the fiscal year. As I wrap up my review of our financial performance, let me emphasize that our guidance reflects the strength of our results here today, initial trends in the fourth quarter, and our ongoing confidence in our differentiated business model. Rob, we are now ready to take questions.